New report on the Top 10 CMOs in China report added in Visionshopsters
Introduction
This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other leading players are also examined.
Features and benefits
* Analyze the competitive positioning and outlook of the leading Chinese CMOs.
* Assess the projected growth of the CMO market in China.* Understand the drivers and resistors of contract manufacturing market in China.
* Discover contract manufacturing deals that are shaping the development of the market.
* Evaluate the potential growth of contract bio-manufacturing in China.
Highlights
China has emerged as one of the leading cost-competitive and quality manufacturing hubs for many multinationals including big pharma companies. Rising cost pressures compounded with economic crisis have continued to drive pharmaceutical companies to seek the cost advantages offered by Chinese CMOs.Developing finished dose exports to developed markets and gaining strength in higher margin services such as high-potency APIs and biologics will be key strategies for Chinese CMOs to overcome intense competition.The drivers of Chinese CMO market include the country's extensive scientific talent pool, and low cost of labor and raw materials. Concerns over intellectual property and product quality as well as competition from other emerging nations are the key market resistors.
Your key questions answered
* How is the contract manufacturing market evolving globally and in China?
* What are the growth strategies of Chinese CMOs such as WuXi AppTec, Shandong Xinhua, Zhejiang Hisun, Zhejiang Huahai, and Chongqing Huapont?
* Which Chinese CMOs plan to offer contract bio-manufacturing services?
* How are growth strategies of Chinese CMOs such as WuXi AppTec, Shandong Xinhua, Zhejiang Hisun, Zhejiang Huahai, and Chongqing Huapont evolving?
Table Of Contents :
Executive Summary
Industry overview
Asymchem Laboratories
Beijing Second Pharmaceutical
Chongqing Huapont Pharmaceutical
Porton Fine Chemicals
Shandong Xinhua Pharmaceutical
Tianjin Pharmaceutical
Venturepharm Laboratories
WuXi AppTec
Zhejiang Hisun Pharma
Zhejiang Huahai Pharmaceutical
Other Key Players
About the author
Disclaimer
Scope and methodology
Scope
Methodology
Industry overview
Summary
Introduction
Overview of the global pharmaceutical contract manufacturing industry
Contract bio-manufacturing is a major opportunity
Key success factors for CMOs
Contract manufacturing industry in Asia
Contract manufacturing industry in China
China's regulatory framework
Intellectual property protection impacting Chinese CMO industry
API versus finished dose supply
Contract bio-manufacturing in China
Market dynamics
Asymchem Laboratories
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Beijing Second Pharmaceutical
Summary
Company Overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Chongqing Huapont Pharmaceutical
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Porton Fine Chemicals
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategy
SWOT analysis
Shandong Xinhua Pharmaceutical
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Tianjin Pharmaceutical
Summary
Company overview
Business segments
Manufacturing capability
Financial performance
Growth strategies
SWOT analysis
Venturepharm Laboratories
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
WuXi AppTec
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Zhejiang Hisun Pharma
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Zhejiang Huahai Pharmaceutical
Summary
Company Overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Other key players
Summary
Shanghai Pharmaceutical Group
Harbin Pharmaceutical Group
ShangPharma
Ningbo Dahongying Pharmaceutical
Longchem Co.
Appendix
Glossary
To know more about this report & to buy a copy please visit:
http://www.visionshopsters.com/product/12695/The-Top-10-CMOs-in-China.html
Questions and Answers
Article Tags:
top 10
,cmos
,china
,market research
,market research reports
,industry analysis
,business research
,business market research
,industry reports
,market reports
,worldwide reports
,global reports
,world reports
,business reports
In USA, one of the leading brands that offer diverse and high quality products promoting proper hygiene is Difresh USA. If you are looking for the best opportunity to grow and have the opportunity for a new business Difresh USA can help you for they are looking for Exclusive Local Distributors
Getting clean and refresh doesn't sacrifice the place where you are for it should be a habit. Having a healthy body will allow you to do things right and good. And no matter where you are you should practice a healthy and proper hygiene even in little things you do.
Maintaining a healthy and proper hygiene badly needs products that are truly effective and could truly answer our need for this. No matter where we are and at anytime we want to get clean we basically need these products right away and only Difresh USA can supply these in a very easy way
The key reason why some firms thrive while some implode during an financial recession is still a puzzle to many people business-owning business owners. Some wrongly assume that all businesses should suffer via recessionary cycles. But the truth is that some companies are usually essentially recession-proof, and it is not necessarily because they are much larger, better known, or a lot more generously capitalized.
Companies like Arch Coal (ACI) and Massey Energy (MEE) watched his or her stock climbed.
This report explores the range of manufacturing technologies that are available for encapsulating ingredients to change their performance characteristics.
According to the International Energy Agency (IEA), at the end of 2008 the world's total offshore crude oil reserves was 238bn barrels (approximately 18% of the total oil reserves), of which deepwater oil reserves constituted 25bn barrels.
This report provides decision-making support by giving an in-depth analysis of market dynamics, drivers and resistors, and trends in the global mobile handset manufacturing industry between 2009-14.
Pharmaceutical excipients are increasingly being considered as functional ingredients in contrast to their earlier status as non-functional additives.
Discuss this Article
